Implementing a letter template to expedite specialty medication appeal letter submission
- 5 October 2024
- journal article
- research article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 65 (1) , 102262
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Advanced Therapies for Inflammatory Bowel Disease: Navigating Payor and Financial ChallengesCurrent Gastroenterology Reports, 2024
- The PA System: Is Prior Authorization for Dose Escalation of IBD Biologic Therapy a Tolerable Alternative or a Perpetual Annoyance?Digestive Diseases and Sciences, 2023
- Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2023
- Droxidopa management by an integrated health-system specialty pharmacy teamJournal of the American Pharmacists Association, 2022
- Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018JAMA Network Open, 2022
- Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort StudyArthritis Care & Research, 2019
- Impact of pharmacy services on cystic fibrosis transmembrane conductance regulator modulator prescribing at a pediatric cystic fibrosis centerPediatric Pulmonology, 2019
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Integrated specialty pharmacy yields high PCSK9 inhibitor access and initiation ratesJournal of Clinical Lipidology, 2019
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009